Julia is responsible for strategy development, and partnerships at the Wellcome Sanger Institute. Her office works to drive broader academic and industry engagement needed to support the work of the Sanger Institute and the wider Wellcome Genome Campus.
Julia oversees organisational research strategy, research policy, faculty planning and organisational impact. Her team work to increase awareness of the impact and reach of Sanger Institute science to position the Sanger Institute as a source of translational opportunities and raises awareness of the importance and impact of genomics research with government and policy makers.
Julia leads the organisational partnership agenda to enhance genomic research activity through the development and delivery of new partnerships and approaches that bring together stakeholders from academia, industry, funding agencies and government. Julia ensures that the Institute’s Associate Research Programme portfolio consists of high-quality, high-impact research covering the breadth of organisational interests and enhances the profile of the Institute and Faculty across the national and international scientific community.
Julia is a member of the Academy of Medical Sciences FLIER Programme, the BioIndustry Association Genomics Advisory Committee, Chair of the Open Targets Governance Board, President of the Rising Network, member of the Global Gene Corp Scientific Advisory Board and Earth BioGenome Project International Steering Committee.
Previously Julia was Assistant Director of Research at Breakthrough Breast Cancer and Science Programme Manager at the World Cancer Research Fund. As a scientist she was a post-doc at the Karolinska Institute, Sweden and then worked as a researcher at Cancer Research UK and Queen Mary University of London.
